Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / MEDIF - Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found | Benzinga


MEDIF - Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found | Benzinga

New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxiety.

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) said the study was conducted by its subsidiary Harvest Medicine.

Titled "Self-Reported Effects of Illness Severity, Depression and Anxiety in Fibromyalgia Patients: A Large Retrospective Case Series," the study was published in the peer-reviewed American Journal of Endocannabinoid Medicine.

The Study And Key Findings

  • The research included data from 805 patients who indicated fibromyalgia, a pain disorder characterized by chronic widespread pain, non-restorative sleep, fatigue, and impaired cognition, as a primary reason for seeking medical cannabis and had a minimum of one follow-up assessment.
  • The majority of patients (76.1%) reported using ...

Full story available on Benzinga.com

Stock Information

Company Name: Medipharm Labs Corp
Stock Symbol: MEDIF
Market: OTC
Website: medipharmlabs.com

Menu

MEDIF MEDIF Quote MEDIF Short MEDIF News MEDIF Articles MEDIF Message Board
Get MEDIF Alerts

News, Short Squeeze, Breakout and More Instantly...